Search - tctmd.com

Displaying 941 - 960 of 1483

Sort: Relevancy | Date

Presentation TCT 2017

Should a Hybrid Revascularization Strategy for Left Main Disease Be Considered?

Presenter: James B. Hermiller Jr., John D. Puskas

November 01, 2017

Presentation TCT 2017

Heart Team Evidence: Synthesizing the PCI vs CABG Left Main Data From EXCEL, NOBLE, and SYNTAX

Presenter: James B. Hermiller Jr., John D. Puskas, Bernard J. Gersh

November 01, 2017

Presentation TCT 2017

Case Introduction: A Patient With a Complex Distal Left Main Stenosis Case and Mild to Moderate Aortic Stenosis

Presenter: James B. Hermiller Jr., John D. Puskas, Nicolas M. Van Mieghem

November 01, 2017

Presentation TCT 2017

SENIOR: A Randomized Trial of a Bioabsorbable Polymer-Based Metallic DES vs a BMS With Short DAPT in Patients With Coronary Artery Disease Older Than 75 Years

Presenter: Robert A. Harrington, Gregg W. Stone, Olivier Varenne

November 01, 2017

Presentation TCT 2017

TCT 82: Impact of Staging Percutaneous Coronary Intervention in Left Main Artery Disease: Insights from the EXCEL Trial

Presenter: David Hildick-Smith, Nicholas J. Lembo, Carlos Collet, MD

October 31, 2017

Presentation TCT 2017

TCT 13: A First-in-Man Study of the Firesorb Sirolimus Target Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease (FUTURE-I) - One-Year Clinical and Imaging Outcomes

Presenter: Stephan Achenbach, Jacques J. Koolen, Bo Xu

October 31, 2017

Presentation TCT 2017

ReASSESS: Diagnostic Accuracy of FFRCT and SPECT Perfusion Imaging Compared to FFR in Patients With Coronary Artery Disease

Presenter: Y. S. Chandrashekhar, David J. Moliterno, Niels Peter Rønnow Sand

October 31, 2017

Presentation TCT 2017

XINSORB: A Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

Presenter: Thomas F. Luscher, Junbo Ge

October 31, 2017

Presentation TCT 2017

FAVOR II Europe Japan: Diagnostic Accuracy of the Angiographic Quantitative Flow Ratio in Patients With Coronary Artery Disease

Presenter: Robert-Jan van Geuns, Jelmer Westra

October 31, 2017

Presentation TCT 2017

FAVOR II China: Diagnostic Accuracy of the Angiographic Quantitative Flow Ratio in Patients With Coronary Artery Disease

Presenter: Robert-Jan van Geuns, Bo Xu

October 31, 2017

News Conference News TCT 2017

Long-term Absorb BVS Data Continue to Disappoint

Michael O'Riordan

October 31, 2017

Presentation TCT 2017

RECOVERY: A Randomized Trial of a Bioabsorbable Polymer-Based Metallic DES With a Luminal CD34+ Antibody Coating vs a Polymer-Free Metallic DES in Patients With Coronary Artery Disease

Presenter: David P. Faxon, Joseph A. Hill, Ling Tao

October 31, 2017

Presentation TCT 2017

ABSORB II: 4-Year Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

Presenter: Robert-Jan van Geuns, Bernard R. Chevalier

October 31, 2017

Presentation TCT 2017

TCT 73: Off-Pump versus On-Pump Coronary Artery Bypass Surgery for Left Main Revascularization: Insights From the EXCEL Trial

Presenter: Adrian P. Banning, John D. Puskas, Umberto Benedetto, MD

October 31, 2017

Presentation TCT 2017

ABSORB IV: 30-Day Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

Presenter: Patrick W. Serruys, Gregg W. Stone

October 31, 2017

Presentation TCT 2017

ABSORB III: 3-Year Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

Presenter: Patrick W. Serruys, Stephen G. Ellis

October 31, 2017

News Conference News TCT 2017

No Advantage With Hybrid Revascularization for Multivessel Disease: HREVS

Michael O'Riordan

October 30, 2017

Presentation TCT 2017

Does DCB Technology Have an Important Role in Treatment of De Novo Coronary Artery Disease? If Not Today, Tomorrow?

Presenter: Robert A. Byrne, Ran Kornowski, Bernardo Cortese

October 30, 2017

Presentation TCT 2017

CABG Remains the Gold Standard for Left Main Coronary Artery Disease!

Presenter: Robert A. Guyton

October 30, 2017

Presentation TCT 2017

PCI is Now the Preferred Option for Left Main Coronary Artery Disease!

Presenter: Anthony H. Gershlick

October 30, 2017

Advertisement

Should a Hybrid Revascularization Strategy for Left Main Disease Be Considered?

Heart Team Evidence: Synthesizing the PCI vs CABG Left Main Data From EXCEL, NOBLE, and SYNTAX

Case Introduction: A Patient With a Complex Distal Left Main Stenosis Case and Mild to Moderate Aortic Stenosis

SENIOR: A Randomized Trial of a Bioabsorbable Polymer-Based Metallic DES vs a BMS With Short DAPT in Patients With Coronary Artery Disease Older Than 75 Years

TCT 82: Impact of Staging Percutaneous Coronary Intervention in Left Main Artery Disease: Insights from the EXCEL Trial

TCT 13: A First-in-Man Study of the Firesorb Sirolimus Target Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease (FUTURE-I) - One-Year Clinical and Imaging Outcomes

ReASSESS: Diagnostic Accuracy of FFRCT and SPECT Perfusion Imaging Compared to FFR in Patients With Coronary Artery Disease

XINSORB: A Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

FAVOR II Europe Japan: Diagnostic Accuracy of the Angiographic Quantitative Flow Ratio in Patients With Coronary Artery Disease

FAVOR II China: Diagnostic Accuracy of the Angiographic Quantitative Flow Ratio in Patients With Coronary Artery Disease

Long-term Absorb BVS Data Continue to Disappoint

RECOVERY: A Randomized Trial of a Bioabsorbable Polymer-Based Metallic DES With a Luminal CD34+ Antibody Coating vs a Polymer-Free Metallic DES in Patients With Coronary Artery Disease

ABSORB II: 4-Year Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

TCT 73: Off-Pump versus On-Pump Coronary Artery Bypass Surgery for Left Main Revascularization: Insights From the EXCEL Trial

ABSORB IV: 30-Day Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

ABSORB III: 3-Year Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

No Advantage With Hybrid Revascularization for Multivessel Disease: HREVS

Does DCB Technology Have an Important Role in Treatment of De Novo Coronary Artery Disease? If Not Today, Tomorrow?

CABG Remains the Gold Standard for Left Main Coronary Artery Disease!

PCI is Now the Preferred Option for Left Main Coronary Artery Disease!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content